von willebrand factor head neck cancer laboratori abnorm blood coagul factor common patient cancer signific unknown twenty-eight patient head neck cancer time diagnosi twenty-f advanced-stag iii IV patient level factor antithrombin iii plasminogen normal level von willebrand factor vwf antigen function ristocetin cofactor group patient minimum month median month fifteen patient follow-up period von willebrand factor level survivor extrem elev ristocetin cofactor u/dl patient none survivor plasma vwf head neck cancer level time diagnosi prognost therapeut implic 